Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
3055(c) 2950(c) 2895.5(c) 2974.7(c) 3025(c) Last
9 254 13 654 15 346 8 640 5 419 Volume
-2.55% -3.44% -1.85% +2.74% +1.69% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
02/17Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2014 27 149 M
EBIT 2014 5 841 M
Net income 2014 5 077 M
Finance 2014 9 447 M
Yield 2014 1,79%
Sales 2015 30 511 M
EBIT 2015 7 172 M
Net income 2015 6 167 M
Finance 2015 9 571 M
Yield 2015 1,91%
PER 2014 49,77
PER 2015 41,06
EV / Sales 2014 8,97x
EV / Sales 2015 7,98x
Capitalization 252 944 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
3d ago GLAXOSMITHKLINE : Glaxo Says Phase III Shingles Candidate Vaccine Trial Met Endp..
12/11 GLAXOSMITHKLINE : Applies For Ambrisentan Indication Extension In EU
12/04 GLAXOSMITHKLINE : Glaxo To Lay Off Hundreds Of Workers In The US - Reports
11/30 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo plans to cut US jobs in restructuring
11/28 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo fired executive who raised SA race compl..
11/28 GLAXOSMITHKLINE : PRESS: Glaxo Fires Executive Who Raised Race Complaint - Bloom..
11/27 GLAXOSMITHKLINE : Ebola Vaccine Progressing At "Unprecedented Rate"
11/27 Glaxo's Deal With Novartis Is Approved By US Regulator FTC
More news
Sector news
7h ago Fear factor fades as global M&A hits seven-year high
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
2d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF